Skip to content
Back to MRX

Marex Group Ltd

Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.

Since Nov 18, 2025
Transactions
48
Purchases
0
Sales
48
Purchase value
$0.00
Sale value
$19.82M

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

Paolo TonucciSee Remarks
4Rule 10b5-1 plan disclosed
Filed Nov 12, 2026Period of report Nov 9, 20260001193125-26-458309
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleNov 9, 2026
Ordinary SharesF1F23,196$67.8914$216.98K1,249,709Direct
SaleNov 9, 2026
Ordinary SharesF1F310,760$68.7356$739.60K1,238,949Direct
SaleNov 9, 2026
Ordinary SharesF1F4F52,712$69.4058$188.23K1,236,237Direct
Filing footnotes · 5
  1. F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on October 22, 2025.
  2. F2The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $67.175 to $68.1625, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. F3The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $68.1775 to $69.1725, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. F4The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $69.175 to $69.885, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  5. F5The number of ordinary shares reported herein includes 220,746 shares underlying unvested deferred bonus plan awards previously granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award.
Open on SEC EDGAR
Born Simon Van DenPresident
4Rule 10b5-1 plan disclosed
Filed Nov 9, 2026Period of report Nov 5, 20260001193125-26-453555
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleNov 5, 2026
Ordinary SharesF1F26,422$64.7773$416.00K1,448,654Direct
SaleNov 5, 2026
Ordinary SharesF1F36,215$65.813$409.03K1,442,439Direct
SaleNov 5, 2026
Ordinary SharesF1F44,451$66.6635$296.72K1,437,988Direct
SaleNov 5, 2026
Ordinary SharesF1F52,046$67.6775$138.47K1,435,942Direct
SaleNov 5, 2026
Ordinary SharesF1F63,101$68.695$213.02K1,432,841Direct
SaleNov 5, 2026
Ordinary SharesF1F7F8221$69.3644$15.33K1,432,620Direct
Filing footnotes · 8
  1. F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on June 12, 2026.
  2. F2The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $64.17 to $65.16 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. F3The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $65.17 to $66.155 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. F4The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $66.1725 to $67.165 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  5. F5The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $67.2075 to $68.13 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  6. F6The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $68.17 to $69.0375 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  7. F7The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $69.24 to $69.61 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  8. F8The number of ordinary shares reported herein includes 272,659 shares underlying unvested deferred bonus plan awards previously granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award.
Open on SEC EDGAR
Born Simon Van DenPresident
4Rule 10b5-1 plan disclosed
Filed Oct 14, 2026Period of report Oct 12, 20260001193125-26-421661
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleOct 12, 2026
Ordinary SharesF1F214,012$71.986$1.01M1,456,336Direct
SaleOct 12, 2026
Ordinary SharesF1F3F41,260$72.6308$91.51K1,455,076Direct
Filing footnotes · 4
  1. F1The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on June 12, 2026
  2. F2The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $71.35 to $72.34 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. F3The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $72.355 to $72.98 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. F4The number of ordinary shares reported herein includes (i) 20,367 shares underlying the Issuer's 2022 Annual Long Term Incentive Plan, and (ii) 272,659 shares underlying deferred bonus plan awards previously granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award.
Open on SEC EDGAR
Paolo TonucciSee Remarks
4Rule 10b5-1 plan disclosed
Filed Oct 14, 2026Period of report Oct 12, 20260001193125-26-421660
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleOct 12, 2026
Ordinary SharesF1F215,506$71.9819$1.12M1,254,065Direct
SaleOct 12, 2026
Ordinary SharesF1F3F41,160$72.6382$84.26K1,252,905Direct
Filing footnotes · 4
  1. F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on October 22, 2025.
  2. F2The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $71.39 to $72.37, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. F3The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $72.42 to $72.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. F4The number of ordinary shares reported herein includes (i) 20,628 shares underlying the Issuer's 2022 Annual Long Term Incentive Plan, and (ii) 220,746 shares underlying deferred bonus plan awards previously granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award.
Open on SEC EDGAR
Paolo TonucciSee Remarks
4Rule 10b5-1 plan disclosed
Filed Sep 16, 2026Period of report Sep 14, 20260001193125-26-393056
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleSep 14, 2026
Ordinary SharesF1F213,714$70.7692$970.53K1,272,523Direct
SaleSep 14, 2026
Ordinary SharesF1F3F42,952$71.3544$210.64K1,269,571Direct
Filing footnotes · 4
  1. F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on October 22, 2025.
  2. F2The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $70.21 to $71.2075, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. F3The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $71.21 to $71.6, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. F4The number of ordinary shares reported herein includes 220,746 shares underlying deferred bonus plan awards previously granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award.
Open on SEC EDGAR
Born Simon Van DenPresident
4Rule 10b5-1 plan disclosed
Filed Sep 16, 2026Period of report Sep 14, 20260001193125-26-393055
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleSep 14, 2026
Ordinary SharesF1F212,616$70.7689$892.82K1,473,003Direct
SaleSep 14, 2026
Ordinary SharesF1F3F42,655$71.3585$189.46K1,470,348Direct
Filing footnotes · 4
  1. F1The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on June 12, 2026.
  2. F2The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $70.23 to $71.225 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. F3The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $71.23 to $71.6 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. F4The number of ordinary shares reported herein includes 272,659 shares underlying deferred bonus plan awards previously granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award.
Open on SEC EDGAR
Rob IrvinDirector · Chief Financial Officer
4
Filed Aug 18, 2026Period of report Aug 14, 20260001193125-26-355407
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleAug 14, 2026
Ordinary SharesF1F33,500$70.9064$248.17K31,246Direct
SaleAug 14, 2026
Ordinary SharesF2F3200$71.865$14.37K31,046Direct
Filing footnotes · 3
  1. F1The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $70.69 to $71.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  2. F2The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $71.71 to $72.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. F3The number of ordinary shares reported herein includes 25,300 shares underlying deferred bonus plan awards previously granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award.
Open on SEC EDGAR
Paolo TonucciSee Remarks
4Rule 10b5-1 plan disclosed
Filed Aug 12, 2026Period of report Aug 10, 20260001193125-26-346805
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleAug 10, 2026
Ordinary SharesF1F212,250$60.6402$742.84K1,270,027Direct
SaleAug 10, 2026
Ordinary SharesF1F33,963$61.6184$244.19K1,266,064Direct
SaleAug 10, 2026
Ordinary SharesF1F4F5455$62.2222$28.31K1,265,609Direct
Filing footnotes · 5
  1. F1The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on October 22, 2025.
  2. F2The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $60.105 to $61.1, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. F3The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $61.17 to $62.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. F4The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $62.16 to $62.265, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  5. F5The number of ordinary shares reported herein includes 220,746 shares underlying deferred bonus plan awards previously granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award.
Open on SEC EDGAR
Paolo TonucciSee Remarks
4Rule 10b5-1 plan disclosed
Filed Jul 15, 2026Period of report Jul 13, 20260001193125-26-304739
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJul 13, 2026
Ordinary SharesF1F211,850$64.2243$761.06K1,287,093Direct
SaleJul 13, 2026
Ordinary SharesF1F34,584$64.8496$297.27K1,282,509Direct
SaleJul 13, 2026
Ordinary SharesF1F4F5232$65.7301$15.25K1,282,277Direct
Filing footnotes · 5
  1. F1The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on October 22, 2025.
  2. F2The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $63.645 to $64.645, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. F3The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $64.65 to $65.57, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. F4The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $65.715 to $65.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  5. F5The number of ordinary shares reported herein includes 220,746 shares underlying deferred bonus plan awards previously granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award.
Open on SEC EDGAR
Ian T LowittDirector · Chief Executive Officer
4Rule 10b5-1 plan disclosed
Filed Jul 15, 2026Period of report Jul 13, 20260001193125-26-304738
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJul 13, 2026
Ordinary SharesF1F227,398$64.1857$1.76M2,803,960Direct
SaleJul 13, 2026
Ordinary SharesF1F38,957$64.9017$581.32K2,795,003Direct
SaleJul 13, 2026
Ordinary SharesF1F4F5787$65.8433$51.82K2,794,216Direct
Filing footnotes · 5
  1. F1The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on March 12, 2026.
  2. F2The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $63.66 to $64.6533, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. F3The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $64.66 to $65.63, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. F4The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $65.66 to $66.09, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  5. F5The number of ordinary shares reported herein includes 194,411 shares underlying deferred bonus plan awards previously granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award.
Open on SEC EDGAR
Paolo TonucciSee Remarks
4Rule 10b5-1 plan disclosed
Filed Jun 16, 2026Period of report Jun 15, 20260001193125-26-272572
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 15, 2026
Ordinary SharesF1F21,658$61.7412$102.37K1,313,951Direct
SaleJun 15, 2026
Ordinary SharesF1F314,199$62.5055$887.52K1,299,752Direct
SaleJun 15, 2026
Ordinary SharesF1F4F5809$62.9994$50.97K1,298,943Direct
Filing footnotes · 5
  1. F1The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on October 22, 2025.
  2. F2The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $60.945 to $61.94, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. F3The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $61.965 to $62.94, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. F4The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $62.945 to $63.075, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  5. F5The number of ordinary shares reported herein includes 220,746 shares underlying deferred bonus plan awards previously granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award.
Open on SEC EDGAR
Ian T LowittDirector · Chief Executive Officer
4Rule 10b5-1 plan disclosed
Filed Jun 16, 2026Period of report Jun 12, 20260001193125-26-272574
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 12, 2026
Ordinary SharesF1F232,813$62.2916$2.04M2,835,688Direct
SaleJun 12, 2026
Ordinary SharesF1F3F44,330$62.9384$272.52K2,831,358Direct
Filing footnotes · 4
  1. F1The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on March 12, 2026.
  2. F2The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $61.81 to $62.80, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. F3The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $62.81 to $63.37, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. F4The number of ordinary shares reported herein includes 194,411 shares underlying deferred bonus plan awards previously granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award.
Open on SEC EDGAR
Thomas TexierGroup Head of Clearing
4Rule 10b5-1 plan disclosed
Filed Jun 3, 2026Period of report Jun 1, 20260001193125-26-256170
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleJun 1, 2026
Ordinary SharesF1F21,303$53.2195$69.35K207,288Direct
SaleJun 1, 2026
Ordinary SharesF1F3F4269$53.9793$14.52K207,019Direct
Filing footnotes · 4
  1. F1The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on September 10, 2025.
  2. F2The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $52.775 to $53.77, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. F3The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $53.775 to $54.155, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. F4The number of ordinary shares reported herein includes 150,563 shares underlying deferred bonus plan awards previously granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award.
Open on SEC EDGAR
Paolo TonucciSee Remarks
4Rule 10b5-1 plan disclosed
Filed May 13, 2026Period of report May 11, 20260001193125-26-221585
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 11, 2026
Ordinary SharesF1F210,934$55.7185$609.23K1,352,423Direct
SaleMay 11, 2026
Ordinary SharesF1F3F45,734$56.315$322.91K1,346,689Direct
Filing footnotes · 4
  1. F1The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on October 22, 2025.
  2. F2The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $55.06 to $56.055 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. F3The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $56.065 to $56.74 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. F4The number of ordinary shares reported herein includes 286,871 shares underlying deferred bonus plan awards previously granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award.
Open on SEC EDGAR
Thomas TexierGroup Head of Clearing
4Rule 10b5-1 plan disclosed
Filed May 5, 2026Period of report May 1, 20260001193125-26-206352
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleMay 1, 2026
Ordinary SharesF1F211,821$52.8713$624.99K230,837Direct
SaleMay 1, 2026
Ordinary SharesF1F3F42,606$53.5287$139.50K228,231Direct
Filing footnotes · 4
  1. F1The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on September 10, 2025.
  2. F2The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $52.42 to $53.415, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. F3The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $53.42 to $53.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. F4The number of ordinary shares reported herein includes 192,348 shares underlying deferred bonus plan awards previously granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award.
Open on SEC EDGAR
Born Simon Van DenPresident
4Rule 10b5-1 plan disclosed
Filed Apr 22, 2026Period of report Apr 20, 20260001193125-26-170353
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleApr 20, 2026
Ordinary SharesF1F212,624$50.9165$642.77K1,509,605Direct
SaleApr 20, 2026
Ordinary SharesF1F3F4641$51.7098$33.15K1,508,964Direct
Filing footnotes · 4
  1. F1The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on December 12, 2025.
  2. F2The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $50.51 to $51.34 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. F3The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $51.56 to $52.115 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. F4The number of ordinary shares reported herein includes 383,741 shares underlying deferred bonus plan awards previously granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award.
Open on SEC EDGAR
Paolo TonucciSee Remarks
4Rule 10b5-1 plan disclosed
Filed Apr 15, 2026Period of report Apr 13, 20260001193125-26-156983
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleApr 13, 2026
Ordinary SharesF1F26,760$50.6012$342.06K1,373,263Direct
SaleApr 13, 2026
Ordinary SharesF1F35,829$51.5564$300.52K1,367,434Direct
SaleApr 13, 2026
Ordinary SharesF1F4F54,077$52.3578$213.46K1,363,357Direct
Filing footnotes · 5
  1. F1The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on October 22, 2025.
  2. F2The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $50.07 to $51.065 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. F3The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $51.08 to $52.065 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. F4The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $52.09 to $52.65 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  5. F5The number of ordinary shares reported herein includes 286,871 shares underlying deferred bonus plan awards previously granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award.
Open on SEC EDGAR
Born Simon Van DenPresident
4Rule 10b5-1 plan disclosed
Filed Apr 2, 2026Period of report Apr 1, 20260001193125-26-140055
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleApr 1, 2026
Ordinary SharesF1F28,710$43.2683$376.87K1,526,783Direct
SaleApr 1, 2026
Ordinary SharesF1F3F44,554$43.9697$200.24K1,522,229Direct
Filing footnotes · 4
  1. F1The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on December 12, 2025.
  2. F2The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $42.77 to $43.7650 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. F3The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $43.77 to $44.29 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. F4The number of ordinary shares reported herein includes 383,741 shares underlying deferred bonus plan awards previously granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award.
Open on SEC EDGAR
Thomas TexierGroup Head of Clearing
4Rule 10b5-1 plan disclosed
Filed Apr 2, 2026Period of report Apr 1, 20260001193125-26-140052
TransactionSecuritySharesPriceValueHeld afterOwnership
SaleApr 1, 2026
Ordinary SharesF1F29,589$43.2754$414.97K247,496Direct
SaleApr 1, 2026
Ordinary SharesF1F3F44,838$43.9743$212.75K242,658Direct
Filing footnotes · 4
  1. F1The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on September 10, 2025.
  2. F2The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $42.77 to $43.7650 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. F3The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $43.77 to $44.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. F4The number of ordinary shares reported herein includes 192,348 shares underlying deferred bonus plan awards previously granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award.
Open on SEC EDGAR

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.